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Idiopathic generalized epilepsy (IGE) is a class of genetically determined, phenotypically related epilepsy syndromes.
Linkage analysis identified a chromosome 18 locus predisposing to a number of adolescent-onset IGEs. We report
a single-nucleotide polymorphism (SNP) association analysis of the region around the marker locus with the high
LOD score. This analysis, which used both case-control and family-based association methods, yielded strong
evidence that malic enzyme 2 (ME2) is the gene predisposing to IGE. We also observed association among subgroups
of IGE syndromes. An ME2-centered nine-SNP haplotype, when present homozygously, increases the risk for IGE
(odds ratio 6.1; 95% confidence interval 2.9–12.7) compared with any other genotype. Both the linkage analysis
and the association analysis support recessive inheritance for the locus, which is compatible with the fact that ME2
is an enzyme. ME2 is a genome-coded mitochondrial enzyme that converts malate to pyruvate and is involved in
neuronal synthesis of the neurotransmitter g-aminobutyric acid (GABA). The results suggest that GABA synthesis
disruption predisposes to common IGE and that clinical seizures are triggered when mutations at other genes, or
perhaps other insults, are present.
Idiopathic generalized epilepsy (IGE [MIM 600699]) is
one of the most common forms of epilepsy, representing
∼30% of all epilepsies (Annegers 1994). Diagnostically,
the classification of different forms of IGE is dependent
on the specifics of seizure characteristics, including type(s)
of seizures, age at onset, timing of seizures, factors pre-
cipitating seizures, etc. (International League Against Ep-
ilepsy 1989). The most important aspect of syndrome
classification in IGE is the type of seizures seen, of which
there are usually three forms: myoclonic seizures (bilat-
eral brief jerks of the upper and sometimes lower limbs),
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absence seizures (brief staring spells with loss of con-
sciousness), and generalized tonic-clonic seizures, which
involve loss of consciousness and generalized convul-
sions. The IGEs usually begin in childhood and adoles-
cence and are primarily, if not exclusively, genetic
(Greenberg et al. 1992). The problem for genetic studies
is that not only do the syndrome characteristics overlap,
thus making the phenotype definition for genetic studies
unclear, but different IGE syndromes frequently occur
within the same family (Beck-Mannagetta and Janz
1991). This mixed familiality further complicates phe-
notype definition. The mode of inheritance of the IGEs
is complex and likely involves an oligogenic model in
which several genes must interact to produce a pheno-
type (Greenberg et al. 1988a, 1992; Durner et al. 2001).
There appear to be several loci, some of which are spe-
cific for certain seizure types—for example, myoclonic
seizures may be determined in part by a gene on chro-
mosome 6, BRD2 (Greenberg et al. 2000; Pal et al.
2003), whereas absence seizures may be influenced by
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Table 1
List of SNPs Used in the Analysis and Their
Chromosomal Positions
SNP Numbera SNP Name
SNP Position on
Chromosome 18
(kb)
1 rs3752087 46442.427
2 rs3892158 46452.5
3 rs1370484 46481.329
4 rs4940007 46510.479
5 rs1470325 46525.278
6 rs1954882 46542.655
7 rs2276186 46579.802
8 rs2849233 46583.54
9 rs2255672 46585.354
10 rs2586775 46588.141
11 rs2218369 46592.104
12 rs2586770 46595.637
13 rs2849239 46596.829
14 rs2586760 46615.12
15 rs2586761 46618.445
16 rs1822459 46626.114
17 rs674351 46639.943
18 rs584087 46644.537
19 rs585344 46650.854
20 rs608781 46659.313
21 rs642698 46674.972
22 rs674210 46698.94
23 rs645088 46708.89
24 rs649224 46710.649
25 rs654136 46716.191
26 rs685373 46732.828
a rs674965 46744.48
27 rs2027735 46757.401
28 rs620898 46761.135
29 rs2156010 46789.476
b rs4390682 46804.44
c rs10502913 46820.258
30 rs3764465 46823.359
31 rs3764466 46823.474
d rs2276163 46827.376
32 rs2298617 46855.39
33 rs2282543 46945.582
34 rs1893379 46970.523
35 rs1893378 46970.847
NOTE.—See table A1 of appendix A (online
only) and appendix B (online only) for further in-
formation regarding SNP primers and laboratory
conditions.
a SNPs a–d were added for analysis of the LD
region; see text for details.
a gene or genes on chromosome 5 (Durner et al. 2001).
However, we have identified one locus on chromosome
18 that appears to be common to all the adolescent-
onset IGE syndromes we studied: juvenile myoclonic ep-
ilepsy (JME [MIM 606904]), juvenile absence epilepsy
(JAE [MIM 607631]), and epilepsy with generalized
tonic-clonic seizures (EGTCS). Here, we report the iden-
tification of that locus and of a specific SNP haplotype
that conveys a sixfold increase in the odds of disease for
these IGEs.
Our previous linkage analysis results showed a maxi-
mum two-point LOD score of 5.2 at D18S474, under a
recessive model, with evidence of heterogeneity (Durner
et al. 2001). The data consisted of many small nuclear
families. Unambiguous recombinants, which would have
allowed us to limit the candidate region, could not be
identified. Because simulation studies of linkage suggested
that, at LOD scores 15, the sought-for locus was likely
to lie within 3 cM of the peak (Greenberg and Abreu
2001), we started the search for association at the point
of maximum evidence for linkage and typed SNPs on
either side of D18S474 (dbSNP Home Page).
Probands had received diagnoses of one of the follow-
ing IGE syndromes: JME, JAE, or EGTCS. Study-eligi-
bility criteria have been described elsewhere (Greenberg
et al. 1995). All subjects signed informed consent forms
and were interviewed in person to confirm the diagnosis,
to confirm that study entry criteria were met, and to col-
lect blood for DNA extraction. Subjects for the case-con-
trol analysis included 156 patients with IGE (88 with
JME; 68 with JAE  EGTCS) and 126 randomly chosen
controls of European origin. For family-based association,
we included 108 families (59 with JME; 49 with JAE 
EGTCS) and used the program TRANSMIT (D. Clayton’s
Web site) to evaluate excess transmission. All family mem-
bers were included, so that maximum information was
obtained even from families missing a parent, but only
the proband was used to test for transmission distortion.
We used the program SNPHAP to infer haplotypes (Clay-
ton and Jones 1999). We SNP-typed 35 SNPs in the region
of D18S474. The SNP names and positions are listed in
table 1. We also used the program GOLD (Abecasis and
Cookson 2000) to examine the marker-marker linkage
disequilibrium (LD) in the region.
SNPs centromeric to D18S474 showed strong and
consistent evidence of allelic (as opposed to genotypic
[see below]) association in both case-control (fig. 1) and
family-based (fig. 2) association studies. For the infor-
mative loci between rs674351 and rs654136, the SNPs
in the region of malic enzyme 2 (ME2) and its putative
promoter, the P values from the case-control association
analysis ranged from .010 to .0001.
One of the most important questions in the genetics
of IGE involves phenotype definition. Results of our pre-
vious linkage analysis (Durner et al. 2001) suggested that
most families with the forms of adolescent-onset IGE we
studied showed linkage to D18S474. However, whereas
JME is genetically linked to chromosome 6, other forms
of IGE are not (Greenberg et al. 1995; Durner et al.
1999). We thus performed separate association analyses
for JME versus non-JME (non-JME p combined JAE 
EGTCS). Both subsets of patients showed the same pat-
tern of association as we saw in the total IGE results,
with strong consistent associations with the SNPs in the
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Figure 1 Evidence for association of adolescent-onset IGE on chromosome 18. The graph shows the x2 based on the case-control analysis
for each SNP tested in this region, which is just centromeric to marker D18S474. There appear to be two peaks, the first of which occurs
directly over the promoter and locus for ME2. The second occurs in a region of no known genes that exhibits evidence of strong marker-
marker disequilibrium. ME2 is located between SNP locations 200 and 300. The origin of the X-axis in figures 1–3 is the first SNP (rs3752087),
which is located at position 46442.427 kb. SNP numbers are given next to each data point.
ME2 region, as well as with SNPs just telomeric to ME2
(fig. 3).
We then asked whether there was a specific haplotype
in the ME2 region that was more prevalent in probands
with IGE than in controls. Including only individuals
whose haplotype probability was 10.9, we inferred hap-
lotypes for probands and controls in the IGE data set
for a nine-SNP-long haplotype covering a 76-kb region
encompassing ME2 and the three SNPs just centromeric
to it (table 2). (These latter three SNPs lie in or near the
putative promoter region of ME2, in a region where
there are no known genes and few ESTs [AI024301,
BX115263, and AW182546]). Because the original link-
age analysis supported recessive inheritance (Greenberg
and Berger 1994; Durner et al. 2001), we examined the
frequency of homozygotes carrying the nine-SNP hap-
lotype versus other genotypes. (We note that, unlike
haplotyping heterozygous haplotype alleles by use of
case-control data, haplotyping homozygotes is without
ambiguity, because there is only one type of base at each
locus of the haplotype.) We identified homozygotes for
this haplotype and compared the odds of disease in ho-
mozygotes with that for any other genotype. We found
that 35% of cases were homozygous for the nine-SNP
haplotype, compared with 8% of controls. The x2 for
the case-control association was 30 (1 df; ).P ! .0001
The odds of disease, given homozygosity, was 6.1 times
the odds for any other genotype (95% CI 2.9–12.7).
Telomeric to the maximum indication of association
at the ME2 locus is a second peak suggesting allelic
association. We investigated the marker-marker LD in
this region (fig. 4) and found an ∼200-kb region of
strong LD that ends just centromeric to the start of the
ME2 locus. We also investigated the homozygous hap-
lotype association evidence of this peak and compared
the results with those in the ME2 region. To make this
analysis comparable to the ME2 region analysis, we
typed four more SNPs in this region (SNPs a–d in table
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Figure 2 Evidence for association in IGE, from family-based association analysis rather than case-control analysis. SNP numbers are given
next to each data point.
1, to bring the total to seven). The region spanned by
this seven-SNP haplotype is 10 kb shorter than that
spanned by the nine-SNP haplotype over ME2. Thus,
the ME2 region has a larger SNP haplotype and has less
marker-marker LD, circumstances that, compared with
the LD region, should decrease the frequency of ho-
mozygotes. In fact, we observed that, in the LD region,
16% of patients were homozygous for the seven-SNP
haplotype, versus 3% of controls—a difference of 13%,
compared with a 27% difference between homozygotes
among cases and controls over the ME2 region. The
odds of disease for a carrier of two copies of this seven-
SNP haplotype is 5.96 (95% CI 2.03–17.5; );P p .001
this CI is wider than that for ME2 and represents more
variability in the estimate of the odds ratio.
The homozygote haplotype analyses support the con-
clusion that the ME2 region, and not the nearby LD
region, contains the IGE-related gene. The meaning of
this second peak, therefore, remains unclear. The second
peak could be the result of the block of LD extending
into the ME2 region in a subset of patients, creating a
“shadow” peak. There are two known genes in that
region telomeric to ME2: MADH4 (MIM 600993),
thought to be a transcription factor related to cancer,
and ELAC1 (MIM 608079), possibly a tumor-suppres-
sor locus. Neither appears related to brain structure or
function.
It is also significant that the results of both the hap-
lotype analysis and the original linkage analysis sup-
ported recessive inheritance. Enzyme-related diseases
tend to show recessive inheritance. Since ME2 is an en-
zyme, the observation of recessiveness lends added sup-
port to the idea that ME2 is the IGE locus in this region.
A previous genetic study of the IGE syndrome JME
suggested, in part, recessive inheritance for an IGE gene
(Greenberg et al. 1988a). The results of a segregation
analysis involving JME (Greenberg et al. 1988a) sup-
ported an oligogenic inheritance model, suggesting that
at least two epistatically interacting loci were responsible
for JME susceptibility. The best-fitting model was one
in which one locus was dominantly inherited and one
recessively inherited. In an oligogenic model, the gene
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Figure 3 Evidence for association in two separate diagnostic groups with adolescent-onset IGE: JME (left) and non-JME (right) IGE.
Non-JME IGE consists of the two groups: JAE and EGTCS. There were 88 JME cases and 68 JAE  EGTCS cases. The results shown are for
case-control analysis. SNP numbers are given next to each data point. Results (not shown) for family-based association were similar for JME,
but the sample size for non-JME was not sufficiently large to reach significance.
Table 2
Bases of the Inferred Nine-SNP
Haplotype Located in the Promoter
Region and within the ME2 Locus
That Had the Highest Probability in
Patients versus Controls
SNP Name Base
rs674351 A
rs584087 A
rs585344 C
rs608781 A
rs642698 G
rs674210 A
rs645088 C
rs649224 C
rs654136 A
NOTE.—The haplotype was found
in 81% of patients and 60% of con-
trols. When present homozygously, it
was found in 35% of patients and 8%
of controls.
frequencies of the disease alleles must be high if the pop-
ulation prevalence is at all appreciable, because disease-
related alleles must be present at several loci; hence, the
proposed high frequency (60%) of the nine-SNP hap-
lotype is predictable. We previously reported evidence
that the BRD2 locus on chromosome 6 is EJM1, the
gene that predisposes to a common form of JME (Pal
et al. 2003), and the linkage analysis and analysis of
SNPs and haplotypes of BRD2 supported dominant in-
heritance (Greenberg et al. 1988b, 2000; Durner et al.
1991; Weissbecker et al. 1991). Thus, the results of both
linkage analysis and allelic and genotypic association
studies of families with JME and other IGE syndromes
have identified two loci that follow the prediction of the
segregation analysis.
How do these results help explain the observations of
the phenotypic overlap and co-occurrence of different
IGE syndromes within families? According to the hy-
pothesis of Durner et al. (2001), the variety of seizure
types seen in families with IGE is explained by genes
that are specific for different seizure types (rather than
IGE syndromes), genes that may interact (either directly
or indirectly) with a more general epilepsy susceptibility
locus. Supporting this hypothesis is (1) suggestive evi-
dence of linkage to chromosome 8 for families identified
through patients with absence and/or tonic-clonic sei-
zures (but without myoclonus) (Durner et al. 1999), (2)
evidence of a locus on chromosome 5 that conveys sus-
ceptibility to absence seizures (Durner et al. 2001), (3)
the chromosome 6 locus predisposing to myoclonic sei-
zures (but not to JAE or EGTCS) (Greenberg et al.
1995), and (4) the identification of ME2 as the likely
locus that conveys overall IGE susceptibility.
ME2 is a nuclear genome-coded enzyme that localizes
in the mitochondria and is expressed in the brain. Its
144 Am. J. Hum. Genet. 76:139–146, 2005
Figure 4 Graph of marker-marker LD in the studied region. The colors correspond to the LD measure D′, with red showing the strongest
evidence for LD and blue the weakest. The promoter region of ME2 begins just after SNP rs1822459; ME2 ends at about SNP rs654136. Note
that LD appears to become most pronounced starting just after the ME2 locus. We suggest that the second peak in association evidence seen
in figures 1–3 is due to the LD with ME2 and not to an independent disease association. The plot uses all SNPs listed in table 1.
primary function appears to be reversibly catalyzing
NADP- and NADPH (nicotinamide adenine dinucleo-
tide phosphate)–dependent oxidative decarboxylation of
malate to pyruvate and carbon dioxide. However, it also
is indirectly involved in the synthesis of g-aminobutyric
acid (GABA) in neurons, in that it supplies a perhaps
critical pool of pyruvate for GABA synthesis (Hassel
2001). The connection of GABA to epilepsy suscepti-
bility is compelling. GABA is the main inhibitory neu-
rotransmitter in the CNS, and many antiepilepsy drugs
are known to modulate the GABA neurotransmitter
system (Meldrum 1982). Mutations in GABA receptors
play a role in susceptibility to some forms of epilepsy
(Baulac et al. 2001), and GABA is involved in modu-
lation of spike-wave activity (Lang et al. 1996). ME2
activity is reported to be highly enriched in mitochondria
from cortical synaptic terminals, compared with mito-
chondria from cerebellar or cultured cortical neurons
(McKenna et al. 2000), and it may also be involved in
the glutamate cycle in neurons (Hassel and Brathe 2000).
The finding that ME2, an enzyme related to GABA syn-
thesis, is strongly linked to and associated with IGE sug-
gests that disruptions in GABA synthesis in the brain
may change the overall threshold of cortical excitability,
allowing other mechanisms to trigger specific types of
seizures, types determined by malfunctions in other
genes. This would explain the observed variety of IGE
syndromes, with their overlapping symptoms and mul-
tiple seizure types, as well as the occurrence of different
IGE syndromes and seizure types within the same family.
The BRD2 locus has been suggested as playing a
strong role in a common form of JME. Both the BRD2
locus and ME2 have been shown to be linked and as-
sociated with JME, but their functions suggest no ob-
vious interaction. BRD2 is thought to interact directly
with H4 histones during DNA transcription (Kanno et
al. 2004). The nature of both of these proteins is so
fundamental to cell functioning that it suggests that the
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mechanisms leading to IGE may be quite subtle and may
operate during brain development.
Although there have been a number of reports of loci
linked to the phenotype of IGE (Charlier et al. 1998;
Escayg et al. 2000; Cossette et al. 2002; Kananura et al.
2002; Haug et al. 2003), they are almost exclusively
linkage analyses of single or a few large pedigrees with
autosomal dominant inheritance; with multiple affected
members, sometimes with phenotypes not typical of
IGE; and with forms of epilepsy variant to the classically
described syndromes. Such families are atypical of the
inheritance patterns observed in families of the common
IGEs seen in clinics. The loci and the putative mutations
identified at those loci have not been shown to influence
the common IGEs.
This report presents analysis of an IGE locus based
on data from families collected specifically for common
forms of IGE, in a genomic region previously identified
through linkage analysis. The linkage and association
evidence suggests that ME2 is a major susceptibility lo-
cus for IGE. If confirmed, it may suggest that a general
susceptibility to adolescent-onset IGE could be due to a
disruption in GABA synthesis, which sets the stage for
a second insult to trigger seizures.
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